anti-wrinkle, anti-aging, lines, wrinkles      reduce lines wrinkles botox 




 





 

Home


Ordering ANYWHERE in the world

Ordering from SOUTH AFRICA

Guarantee and return policy

Formulation

Clinical information

References

Contact us

Privacy statement

Anti-aging and related articles



 







Clinical references


On this page you will find links below to pages dealing with specific areas on which the formulators worked when putting together our effective anti-wrinkle and anti-aging Créme de Vie product.


anti-wrinkle anti-aging


Below that, you will find the clinical references which are referred to in our on-line documentation.


anti-wrinkle and anti-aging


Clinical references
    


  1. Benedetto, A.V. Environment and skin aging. Clin. Derm. 16, 129-139 (1998)
    2. 

  2. Stegman, S.J., Tromovitch, T.A., Glogau, R.G. The skin of the aging face in cosmetic dermatologic surgery. 2nd edn. St. Louis. MO: Mosby year book, 5-15(1990)
    3. 

  3. Benedetto, A.V. The cosmetic use of Botulinum neurotoxin type A. Int. J. Derm. 38, 641-655 (1999)
    4. 

  4. Becker-Wegerich, P.M., Rauch, L. and Ruzicka, T. Botulinum toxin a successful decollete rejuvenation. Dermatol. Surg. 28, 168-171 (2002).
    5. 

  5. Frankel, A.S. Botox for rejuvenation of the periorbital region. Facial Plast. Surg. 15, 255-262 (1999).
    6. 

  6. Johnson, E.A. Clostridial toxins as therapeutic agents: Benefits of nature's most toxic proteins. Annu. Rev. Microbiol. 53, 551-575 (1999).
    7. 

  7. Chen, Y.A. and Scheller, R.H. SNARE-mediated membrane fusion. Nat. Rev. Mol. Cell Biol. 2, 98-106 (2001).
    8. 

  8. Gutierrez, L.M., Canaves, J., Ferrer-Montiel, A., Reig, J.A., Montal, M. and Viniegra, S. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca 2'-dependent exocytosis in chrornaffin cells. FEBS Lett. 372, 39-43 (1995).
    9. 

  9. Gutierrez, L.M., Viniegra, S., Rueda, J., Ferrer-Montiel, A.V., Canaves, J.M. and Montal, M. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chrornaffin cells. J. Biol. Chem. 272, 2634-2639 (1997).
    10. 

  10. Ferrer-Montiel, A.V, Gutierrez, L.M., Apland, J.P., Canaves, J.M., Gil, A., Viniegra, S., Biser, J.A., Adler, M. And Montal, M. The 26-mer peptide released from SNAP25 by botulinum neurotoxin E inhibits vesicle docking. FEBS Lett. 435, 84-88 (1998).
    11. 

  11. Blanes-Mira, C., lb6hez, C., Fernandez-Ballester, G., Planells-Cases, R., P6rezPay6, E., Ferrer-Montiel, A. (2001). Thermal stabilization of the catalytic domain of botulinum neurotoxin E by phosphorylation of a single tyrosine residue. Biochemistry 40, 2234-2242 (2001).
    12. 

  12. Ferrer-Montiel, AN., Canaves, J.M., DasGupta, BR, Wilson, M.C. and Montal, M. Tyrosine phosphorylation modulates the activity of clostridial neurotoxins. J. Biol. Chem. 271, 31, 18322-18325 (1996).
    13. 

  13. Hayashi, T., Yamasaki, S., Nauennburg, S., Binz, T. and Niemann, H. Disassembly of the reconstituted synaptic vesicle membrane fusion complex in vitro. EMBO J. 14, 2317-2325 (1994).
    14. 

  14. A. Ferrer Monteil et al, The Journal of Biological Chemistry, 1977, 272, 2634-2638
    15. 

  15. Research on Rosehip Oil. Primal Nature Products, Australia
    16. 

  16. Frank S. D'Amelio Sr., Botanicals - A Phytocosmetic Desk refernce, CRC Press, 1999.
    17. 

  17. Evaluation of  the acute toxicity of a synthetic polyalphaolefin-based hydraulic fluid, E.R.Kinkhead, S.S.Henry, B.T.Culpepper, E.C.Kimmel, H.F.Leahy, R.S.Kutzman, Naval Medical Research Institute/Toxicology Department, USA, 14.1.1988. 
    18. 

  18. Nexbase 2006 FG: Preliminary toxicity study by dietary administration to F-344 rats for four weeks, T.J.Lawler, Pharmaco: LSR, UK, 22.12.1993. 
    19. 

  19. Nexbase 2006 FG: Toxicity study by dietary administration to F-344 rats for 13 weeks followed by a 4 week reversibility period, S.Cooper, Pharmaco:LSR, UK, November 1994.
    20. 

  20. Huidtesten met Neste Nexbase 2004FG, Nexbase 2006FG en Nexbase 2008FG. Prof. A.Goossens, Contactallergie-Dermatologie, U.Z Sint Rafaël, Leuven, Belgium, May 1999. 
    21. 

  21. 3 H- NEXBASE™ 2006FG (3 H-Hydrogenated poly 1-decene) absorption study in the rat after single and repeated doses. B.A John et. Al, Huntingdon Life Sciencies Ltd, UK, 10.2.1999.
    22. 

  22. 3 H- NEXBASE™ 2006FG, In Vitro dermal penetration study in human skin. Huntingdon Life Sciences Ltd, UK, February 1999.
    23. 

  23. 3 H- NEXBASE™ 2006FG, Percutaneous absorption study in the rat. Huntingdon Life Sciences Ltd, UK, May 1999.
    24. 

  24. Evaluation of the anti wrinkle efficacy of cosmetic products, ProDERM Study-No; 99.068-27, ProDERM Institute for Applied Dermatological Research GmbH, Schenefeld/Hamburg, Germany, September 1999. 
    25. 

  25. Certificate of Chemical Analysis of Free Radicals. Henrik Kunttu, University Of Jyväkylä, Department of Chemistry, 1.12.1999
    26. 

  26. Evaluation of long term efficacy of cosmetics products, ProDerm study number 99.133-28, order number 200501/1, ProDerm Institute for Applied Dermatological Research GmbH, Schenefeld/Hamburg, Germany, February 2000. 
    27. 

  27. Evaluation of long term efficacy of cosmetic products. ProDerm study number 99.133-28, order number 200501/1, ProDerm Institute for Applied Dermatological Research GmbH, Schenefeld/Hamburg, Germany, March 2000. 
    28. 

  28. Polydecene Cosmetic Application Study, Studio Rigano Srl, Milano, Italy, May 2000.
    29. 

  29. Journal of Agricultural Food Chemistry, March 2000, pages 825-828; and Journal of Nutrition, March 2002, pages 461-471
    30. 

  30. Advanced Drug Delivery Reviews, June 2002, pages 587-606; and Cancer Research, June 2002, pages 3138-3143
    31. 

  31. Christakis, G., ed: Nutritional Assessment in Health Programs, American Journal of Public Health, 63:Supplement, November, 1973
    32. 

  32.  M. Passeri and D. Provvedini, [Vitamin E in Geriatric Physiopathology], Acta Vitaminol Enzymol, 5(1), 1983, p. 53-63
    33. 

  33. C. L. Phillips, et al. "Effects of Ascorbic Acid on Proliferation and Collagen Synthesis in Relation to the Donor age of Human Dermal Fibroblast," Journal of Investigative Dermatology, 103(2), August 1994, p.228-232.
    34. 

  34. G. Michaelson, et al., "Effects of Oral Zinc and Vitamin A on Acne", Arch Dermatol, 113(1), January 1977, p.31-36 
    35. 

  35. L. G. Hochman, et al., "Brittle Nails: Response to Daily Biotin Supplementation," Cutis 51(4), April 1993, p. 303-305 
    36. 

  36. H. S. Mitchell, et al. Nutrition in Health and Disease, Lippicott, 1976 
    37. 

  37. A Davis, Let's eat right to keep fit, Unwin, Harcourt Brace Jovanovich Inc. 1954 - 1979
    38. 

  38. Bucher HC, et al. Polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112(4):298-304.
    39. 

  39. Chan J.K., Bruce V.M., McDonald B.E., Dietary alpha-linolenic acid is as effective as oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men. Am J Clin Nutr 1991:53(5):1230-1234.
    40. 

  40. Chisato N, et al. Soy and fish oil and mortality in a Japanese community. Am J Epidemiol 2002;156:824-831.
    41. 

  41. Clandinin MT, et al. Omega-3 fatty acid intake results in a relationship between the fatty acid composition of LDL cholesterol ester and LDL cholesterol content in humans. Biochim Biophys Acta 1997;1346(3):247-252.
    42. 

  42. Croteau, R, et al. Seed lipids of the American Cranberry (Vaccinium macrocarpon), Phytochemistry, Vol.8, 19969, 2219-2222.
    43. 

  43. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343(8911):1454-1459.
    44. 

  44. Dyerberg J. Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr Rev 1986;44(4):125-134.
    45. 

  45. Giovannucci E, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993;85(19):1571-1579.
    46. 

  46. Harvei S, et al. Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 1997;71(4):545-551. 
    47. 

  47. Hu FB, et al. Fish and omega-3 Fatty Acid intake and risk of coronary heart disease in women. JAMA 2002;287(14):1815-1821. 
    48. 

  48. Hu FB, et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999;69(5):890-897.
    49. 

  49. Jenab M, et al. The influence of flaxseed and lignans on colon carcinogenesis and beta-glucuronidase activity. Carcinogenesis 1996;17(6):1343-1348.
    50. 

  50. Layne KS, et al. Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J Nutr 1996;126(9):2130-2140. 
    51. 

  51. Makrides M, et al. A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: effects on visual function and growth. Am J Clin Nutr 2000;71(1):120-129.
    52. 

  52. Nieto N, et al. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 2002;132(1):11-19.
    53. 

  53. Oomah, BD, et al. Characteristics of raspberry (rubus idaeus L.) seed oil. Food Chemistry, 69, 2000, 187-193.
    54. 

  54. Pandalai PK, Pilat MJ, Yamazaki K, et al. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res 1996;16(2):815-820. 
    55. 

  55. Stoll AL, et al. Omega-3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56(5):407-412.
    56. 

  56. Weber C., Podda M., Rallis M., Thiele J.J., Traber M.G., Packer L., Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV-irradiation. Department of Molecular and Cell Biology, University of California-Berkeley 94720-3200, USA. Free radical biology and medicine. 1997;22(5):761-9Kim H.H., Cho S., Lee S.
    57. 

  57.  Kim K.H., Cho K.H., Eun H.C., Chung J.H., Photoprotective and anti-skin-aging effects of eicosapentaenoic acid in human skin in vivo., Department of Dermatology, Seoul National University College of Medicine, Laboratory of Cutaneous Aging Research, Clinical Research Institutes, Seoul National University Hospital, Seoul National University, Korea.Journal of lipid research, 2006 May;47(5):921-30.
    58. 

  58. Henneicke-von Zepelin H.H., Mrowietz U., Farber L., Bruck-Borchers K., Schober C., Huber J., Lutz G., Kohnen R., Christophers E., Welzel D., Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study. Department of Dermatology, University of Kiel, Germany., The British Journal of Dermatology. 1993 Dec;129(6):713-7.
    59. 

  59. Escobar S.O., Achenbach R., Iannantuono R., Torem V. Topical fish oil in psoriasis--a controlled and blind study. Department of Pharmacology, Faculty of Medicine, University of Buenos Aires, Argentina. Clinical and Experimental Dermatology.1992 May;17(3):159-62.
    60. 

  60. Andre P., Hyaluronic acid and its use as a "rejuvenation" agent in cosmetic dermatology. Seminars in Cutaneous Medicine and Surgery. 2004 Dec;23(4):218-22.
    61. 

  61. Brown T.J., Alcorn D., Fraser J.R., Absorption of hyaluronan applied to the surface of intact skin., Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia., The Journal of Investigative Dermatology. 1999 Nov;113(5):740-6.
    62. 

  62. Block, A., and Bettelheim, F.: Water Vapor Sorption of Hyaluronic Acid , Biochim Biophys Acta 201, 69, 1970
    63. 

  63. Brown M. B., Jones S.A., Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. Journal of the European Academy of Dermatology and Venereology : JEADV. 2005 May;19(3):308-18.
    64. 

  64. Weindl G, Schaller M, Schäfer-Korting M, Korting HC:
    65. 

  65. Tammi R, Ripellino JA, Margolis RU, and Tammi M: Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe.  J. Invest. Dermatol. 90: 412-414, 1988.
    66. 

  66. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Agren U, Alhava E, and Kosma V-M: Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res. 58: 342-347, 1998.
    67. 

  67.  Tammi R, Saamanen A-M, Maibach HI, and Tammi M: Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J. Invest. Dermatol. 97: 126-130, 1991.
    68. 

  68. Agren UM, Tammi RH, and Tammi MI: Reactive oxygen species contribute toepidermal hyaluronan catabolism in human skin organ culture. Free Radic. Biol. Med. 23: 996-1001, 1997.
    69. 

  69. Tammi R, Ripellino JA, Margolis RU, Maibach HI, and Tammi M: Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture. J. Invest. Dermatol. 92: 326-332, 1989.
    70. 

  70. Agren UM, Tammi M, and Tammi R: Hydrocortisone regulation of hyaluronan metabolism in human skin organ culture. J. Cell. Physiol. 164: 240-248, 1995.
    71. 

  71. Tuhkanen A-L, Tammi M, and Tammi R: CD44 substituted with heparan sulfate and endo-beta-galactosidase-sensitive oligosaccharides: A major proteoglycan in adult human epidermis. J. Invest. Dermatol. 109: 213-218, 1997.
    72. 

  72. Agren UM, Tammi M, Ryynanen M, and Tammi R: Developmentally programmed expression of hyaluronan in human skin and its appendages. J. Invest. Dermatol. 109: 219-224, 1997.
    73. 

  73. Hall CL, Wang C, Lange LA, and Turley EA: Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J. Cell Biol. 126: 575-588, 1994.
    74. 

  74. MacCallum DK and Lillie JH: Evidence for autoregulation of cell division and cell transit in keratinocytes grown on collagen at an air-liquid interface. J. Skin Pharmacol. 3: 86-96, 199
    75. 

  75. Brown TJ, Alcorn D, Fraser JR, Absorption of hyaluronan applied to the surface of intact skin. , Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia., The Journal of Investigative Dermatology. 1999 Nov:113(5) : 740-6
    76. 

  76. FAO. Red Latinoamericana de Cooperación Técnica en Sistemas Agroforestales. Especies Arbóreas y Arbustivas paralas Zonas Aridas y Semiáridas de América Latina. Caesalpinia spinosa. 1998. 12 pp. (ref. 4785)
    77. 

  77. Tara (Caesalpinia spinosa). www.peruecologico.com
    78. 

  78. Basurto L. Estudio botánico de la Tara. Alnicolsa Productos Agroindustriales, Perú 2000-2001: pp 11. (ref. 4784) 
    79. 

  79. Del Re-Jiménez BL, Amado R. Comparative study of the chemical composition of germ meals from carob, guar and taraseeds. Food Hydrocolloids 1989; 3 (2): 149-156. (ref. 4770) 
    80. 

  80. Commission Directive 96/77/EC. Amended by Commission Directive 98/86/EC. 
    81. 

  81. Reid JS et al. Mechanism and regulation of galactomannan biosynthesis in developing leguminous seeds. BiochemicalSociety Transactions. 1992;20(1):23-26. 
    82. 

  82. McCleary BV et al. The fine structures of carob and guar galactomannans. Carbohydrate Research. 1985; 139: 237-260. 
    83. 

  83. Mulimani VH, Prashanth SJ. Investigating plant galactomannans. Biochemistry and Molecular Biology Education. 2002;30(2): 101-103. 
    84. 

  84. Daas PJ et al.. On the galactosyl distribution of commercial galactomannans. Carbohydrate Research. 2000; 329: 609619. 
    85. 

  85. Daas PJ et al..Toward the recognition of structure-function relationships in galactomannans. J Agric Food Chem. 2002;50(15):4282-9. 
    86. 

  86. Cunningham DC, Walsh KB. Galactomannan content and composition in Cassia brewsteri seed. Australian Journal ofExperimental Agriculture. 2002; 42:1081-1086. 
    87. 

  87. Pasquel A. Gomas:Una aproximación a la industria de alimentos. Revista Amazónica Investigación Alimentaria.2001;1(1): 1-8. 
    88. 

  88. Trivedi et al, 1995
    89. 

  89. Fuchs J, Huflejt ME, Rothfuss LM, Wilson DS, Carcamo G, Packer L. Acute effects of near ultraviolet and visible light on the cutaneous antioxidant defense system. Photochemistry and photobiology. 1989 Dec;50(6):739-44
    90. 

  90. Cockerell CJ: Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000 Jan; 42(1 Pt 2): 11-7.
    91. 

  91. Cohn BA: From sunlight to actinic keratosis to squamous cell carcinoma. J Am Acad Dermatol 2000 Jan; 42(1 Pt 1): 143-4.
    92. 

  92. Drake LA, Ceilley RI, Cornelison RL, et al: Guidelines of care for actinic keratoses. Committee on Guidelines of Care. J Am Acad Dermatol 1995 Jan; 32(1): 95-8.
    93. 

  93. Feldman SR, Fleischer AB Jr, Williford PM, Jorizzo JL: Destructive procedures are the standard of care for treatment of actinic keratoses. J Am Acad Dermatol 1999 Jan; 40(1): 43-7.
    94. 

  94. Glogau RG: The risk of progression to invasive disease. J Am Acad Dermatol 2000 Jan; 42(1 Pt 2): 23-4.
    95. 

  95. Goette DK: Topical chemotherapy with 5-fluorouracil. A review. J Am Acad Dermatol 1981 Jun; 4(6): 633-49.
    96. 

  96. Kurwa HA, Yong-Gee SA, Seed PT, et al: A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999 Sep; 41(3 Pt 1): 414-8.
    97. 

  97. Leffell DJ: The scientific basis of skin cancer. J Am Acad Dermatol 2000 Jan; 42(1 Pt 2): 18-22.
    98. 

  98. Marks R, Rennie G, Selwood TS: Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988 Apr 9; 1(8589): 795-7.
    99. 

  99. Moy RL: Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000 Jan; 42(1 Pt 2): 8-10.
    100. 

  100. No authors listed: Actinic keratoses: scientific evaluation and public health implications. Proceedings of a conference. January 27, 1999. J Am Acad Dermatol 2000 Jan; 42(1 Pt 2): 1-30.
    101. 

  101. Salasche SJ: Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000 Jan; 42(1 Pt 2): 4-7.
    102. 

  102. Winton GB,  Salasche SJ: Dermabrasion of the scalp as a treatment for actinic dam
    103. 

  103. B Eberlein-König & J Ring, Relevance of vitamins C and E in cutaneous photoprotection, Journal of Cosmetic Dermatology, January 2005, Volume 4 Page 4
    104. 

  104. Bissett D.L., Chatterjee R., Hannon D.P., Photoprotective effect of topical anti-inflammatory agents against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatology, Photoimmunology & Photomedicine. 1990 Aug;7(4):153-8.
    105. 

  105. Gensler H.L.,  Magdaleno M.,Topical vitamin E inhibition of immunosuppression and tumorigenesis induced by ultraviolet irradiation. Nutrition and Cancer. 1991;15(2):97-106.
    106. 

  106. Pathak M.A., Robins P., A response to concerns about sunscreens: a report from the Skin Cancer Foundation. The Journal of Dermatologic Surgery and Oncology. 1989 May;15(5):486-7.
    107. 

  107. Darr D., Dunston S., Faust H., Pinnell S., Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants. Acta dermato-venereologica. 1996 Jul;76(4):264-8.
    108. 

  108. Kondo S, Mamada A, Yamaguchi J, Fukuro S., Protective effect of dl-alpha-tocopherol on the cytotoxicity of ultraviolet B against human skin fibroblasts in vitro. Photodermatology, photoimmunology & photomedicine. 1990 Aug;7(4):173-7.
    109. 

  109. Bissett D.L., Chatterjee R., Hannon D.P., Photoprotective effect of topical anti-inflammatory agents against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatology, Photoimmunology & Photomedicine. 1990 Aug;7(4):153-8.
    110. 

  110. Panin G., Strumia R., Ursini F., Topical alpha-tocopherol acetate in the bulk phase: eight years of experience in skin treatment. Annals of the New York Academy of Sciences. 2004 Dec;1031:443-7.
    111. 

  111. Dalle Carbonare M., Pathak M.A., Skin photosensitizing agents and the role of reactive oxygen species in photoaging. Journal of Photochemistry and Photobiology. B, Biology. 1992 Jun 30;14(1-2):105-24.
    112. 

  112. McVean M., Liebler D.C.,  Prevention of DNA photodamage by vitamin E compounds and sunscreens: roles of ultraviolet absorbance and cellular uptake. Molecular Carcinogesis. 1999 Mar;24(3):169-76.
    113. 

  113. Weiser H., 1986
    114. 

  114. Taren D.L., Chvapil M., Weber C.W., Increasing the breaking strength of wounds exposed to preoperative irradiation using vitamin E supplementation.International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition. 1987;57(2):133-7.
    115. 

  115. Bagby, M.O., Comparison of Properties and Function of Jojoba Oil and Its Substitutes, Proceedings from the Seventh International Conference on Jojoba and Its Uses, American Oil Chemists' Society, Champaign, IL, 1988.
    116. 

  116. Brown, James H., Jojoba, HAPPI, October 1984.
    117. 

  117. Brown, J. and K. Dwyer, The Jojoba Potential: An Overview, Proceedings from the Seventh International Conference on Jojoba and Its Uses, American Oil Chemists' Society, Champaign, IL, 1988.
    118. 

  118. Cadicamo, P. and J. Cadicamo, A Study of Jojoba Oi1, Its Derivatives and Other Cosmetic Oi1s, Cosmetics & Toi1etries, Vol. 97, 1982.
    119. 

  119. Castetter, E.F. and R.M. Underhill, Ethnobiological Studies in The Arnerican Southwest, University of New Mexico Bulletin,Biological Series 4, 1935.
    120. 

  120. Christensen, M.S. and E.W. Packman, Skin Surface Softening Effects of Jojoba and Its Derivatives, Proceedings from the Seventh International Conference on Jojoba and Its Uses, American Oil Chemists' Society, Champaign, IL, 1988.
    121. 

  121. Clavilero, F .J ., The History of Lower California, Stanford University Press, Palo Alto, California, Translated 1937.
    122. 

  122. Darr, D.J., Biology of Oxygen Free Radicals, Inter. Conf on Cutaneous Aging (1988)
    123. 

  123. Daugherty, P.M., H.H. Sineath, and T.A. Wastler, Industrial Raw Materials of Plant Origin IV: A Survey of Simmondisia Chinesis, Bull. Eng. Exp. Sta., Georgia lnst. Tech. 15 (13), 1953.
    124. 

  124. Evison, J. and J.F. Chester, Nature, Soap, Perfume, and Cosmetics ,63 (13), November, 1990.
    125. 

  125. Fieser, Louis and Mary Fieser, Basic Organic Chemistry, D.C. Heath and Company, USA 1959.
    126. 

  126. Flider, Frank J., Jojoba: Finally a Real Industry Has Emerged, HAPPI, May, 1987.
    127. 

  127. Greene, R.A., and E.O. Foster, BotlGaz/9.4 826-828, 1933.
    128. 

  128. Green, T.G., T.P. Hilditch, and W.J. Stainsby, J. Chem. Soc. 1936.
    129. 

  129. Hagemann, J.W. and J.A. Rothus, Journal of the American Oil Chemists' Society, Vol. 56, # 629, 1979.
    130. 

  130. Hirai, Y., N. Tonooka, T. Tanigawa, and K. Ito, Application of the Compounds Related to Jojoba in Cosmetics, Proceedings from the Seventh International Conference on Jojoba and Its Uses, American Oil Chemists' Society, Champaign, IL, 1988. pp 305-317
    131. 

  131. Jacobsen, E. et al, Age Related Changes in Wax Ester Secretion Rate in Men and Women, Journal Of lnvestigative Dermatology, 85: 483-485, 1985.
    132. 

  132. Johnson, W. Jr., Final Report on the Safety Assessment of Jojoba Oil and Jojoba Wax, J. of the American College of Toxicology, Vol. 11, No.1, 1992
    133. 

  133. Kadish, A., A Search for the Origin of Jojoba, Proceedings from the Sixth International Conference on Jojoba and Its Uses, Beer-Sheva, Israel, 1984.
    134. 

  134. Katoh, M., M. Taguchi and T. Kunimoto, Current Status of Jojoba Oil Utilization in Cosmetics in Japan, in Proceedings Seventh international Conference on Jojoba and Its Uses, edited by A.R. Baldwin, American Oil Chemists' Society,Champaign, IL, 1988, pp. 318-342.
    135. 

  135. Kono, Y. K. Tomita, H. Katsura, and S. Ohtu, Proceedings from the Fourth International Conference on Jojoba and Its Uses, Hermosillo, Sonora, Mexico, 1980.
    136. 

  136. Libby, H., R.H. Purdy, R.L. Realina and T.A. Lugtu, Cosmetics Based on Jojoba Oil. 1. Oxidation Stability, Proceedings from the Sixth International Conference on Jojoba and Its Uses, Beer-Sheva, Israel, 1984.
    137. 

  137. McClatchey, K.D., in Jojoba: New Crop for Arid Lands; New Raw Material for Industry, National Academy Press, Washington D.C., 1985.
    138. 

  138. McClatchey, K. D., W.J. Ferrell, and C. L. Pierson, Percutaneous Absorption of Jojoba Gil, O Proceedings from the Fourth International Conference on Jojoba and Its Uses, Hermosillo, Sonora, Mexico, 1980.
    139. 

  139. McKinney, R.S. and G.S. Jamieson, Oil & Soap 13,289-292,1936.
    140. 

  140. Miwa, T. K., Structural_Determination and Uses of Jojoba Oil, Journal of the American Oil Chemists' Society, Vol. 61, #2, February, 1984.
    141. 

  141. Miwa, T .K. and J .W. Hagemann, Physical And Chemical Properties of Jojoba Liquid And Solid Waxes, Proceedings from the Second International Conference on Jojoba and Its Uses, Ensenada, Baja California, Mexico, 1976.
    142. 

  142. Miwa, T.K. and G. Spencer, Composition of Jojoba Oil From Nuts Harvested at Different Geographical Regions, Proceedings from the Second International Conference on Jojoba and Its Uses, Ensenada, Baja California, Mexico, 1976.
    143. 

  143. Necks, D.C. and M.P. Doyle, Organic Chemistry, John Wiley & Sons, Inc., New York, New York, 1977.
    144. 

  144. Official and Tentative Methods of the American Oil Chemists' Society, Vol I & Vol. 11, 3rd Edition by W .F .Link, AOCS Press, Champaign, IL, revised 1992.
    145. 

  145. Orkin, M., H.I. Maibach, and M.V. Dahl, Dermatology 1991 Personal Care Products Now lnclude Biologically Active Cosmetics, lnternational News on Fats, Oils, and Related Materials, 1(6), June 1990.
    146. 

  146. Purcell, H. Quality Standards Committee Progress Report, Proceedings from the Sixth Inter- national Conference on Jojoba and Its Uses, Beer-Sheva, Israel, 1984. 
    147. 

  147. Purcell, H., Natural Jojoba Versus Dryness and Free Radicals, Cosmetics and Toiletries Manufacture Worldwide, Aston Publishing Group, Herdfordshire, U.K., 1993. 
    148. 

  148. Purcell, H., Natural Jojoba's Moisture Control and Oxidative Stability Took Millions of Years to Perfect. Cosmetics and Toiletries Manufacture Worldwide, Aston Publishing Group, Herdfordshire, U.K., in press. 
    149. 

  149. Reinhardt, J.G. and J. H. Brown, Jojoba in Cosmetics, Eighth International Conference on Jojoba and Its Uses, Asuncion, Paraguay, 1990.
    150. 

  150. Richey, H.G., Fundamentals of Organic Chemistry, Prentice-Hall, Inc., Englewood Cliffs, New Jersey, 1983. 
    151. 

  151. Ricks, D.J., Jojoba Oil in Cosmetics, Eighth International Conference on Jojoba and Its Uses, Asuncion, Paraguay, 1990. 
    152. 

  152. Ricks, D.J., Functional Natural Oils, Cosmetics & Toiletries, Vol. 106, Feb. 1991, 
    153. 

  153. Sherebraake, W.C. and E.F. Haase, Jojoba: A Wax-Producing Shrub at the Sonoran Desert, Tucsan, AZ, University of Arizona, Office of Arid Land Studies, 1974. 
    154. 

  154. Spencer, G .F .and G .R. List, Specifications, Physical Properties and Methods of Analysis for Jojoba Oil, Proceedings from the Seventh International Conference on Jojoba and Its Uses, American Oil Chemists' Society, Champaign, IL, 1988. 
    155. 

  155. Swern, D., Bailey's Industrial Gil and Fat Products, Vol. 1 (4th edition), John Wiley and Sons, 1979. 
    156. 

  156. Taguchi, M., Test Results On Safety on Jojoba Oil To Be Used For Cosmetics, Proceedings from the Second International Conference on Jojoba and Its Uses, Ensenada, Baja California, Mexico, 1976. 
    157. 

  157. Taguchi, M. and T. Kunimoto, Cosmetics & Toiletries 92 (9), 53,1977.
    158. 





buy anti-aging anti-wrinkle cream





Active ingredients used in Créme de Vie  
Articles of interest
 
anti-aging skin care dermaxime















Information supplied by Rex, Rafferty & Argent Cosmeceuticals (Pty) Ltd  is for general information purposes only - statements about products and health conditions have not been evaluated by the U.S. Food and Drug Administration, and should not be seen as any health claims, and should not be used to diagnose or treat any medical condition.







Home |  Ordering |  Guarantee and return policy |
 Formulation |  Clinical information

 References |  Contact us |  Privacy statement |
 Anti-aging and related articles

South African Orders |  Links to other sites


 






© Copyright Rex, Rafferty & Argent Cosmeceuticals (Pty) Ltd
2001 - 2008.



The entire content of this website is copyrighted - including text, photographs, logos, metatags etc., and no part whatsoever may be copied and used - privately, for educational purposes or publishing or for commercial application - without the written permission of Rex, Rafferty & Argent Cosmeceuticals (Pty) Ltd. 


Créme de Vie™





Our site is kept current and was last updated 3 May 2008.